US Patent RE39282 Nucleic acid derivatives
Patent RE39282 was granted and assigned to Smithkline Beecham Limited on September, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Brendan A. Larder0
Sharon D. Kemp0
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+170 characters)
Article
Patent abstract
This invention relates to a methodology for assessing the sensitivity of an HIV-1 sample to zidovudine and to diagnostic assays for use in such assessment.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent RE039282 Nucleic acid derivatives US Patent RE39282 Nucleic acid derivatives
Infobox
Patent Number
RE03928200
Patent Number
RE3928200
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
RE0392820
Date of Patent
September 12, 2006
0Patent Application Number
102932190
Date Filed
November 12, 2002
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
RE0392820
Date of Patent
September 12, 2006
0Patent Application Number
102932190
Date Filed
November 12, 2002
0Official Website
Patent Primary Examiner
Edits on 7 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 17 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent RE039282 Nucleic acid derivatives
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
RE039282
Date of patent
September 12, 2006
Patent application number
10293219
Date Filed
November 12, 2002
Patent primary examiner
Find more entities like US Patent RE39282 Nucleic acid derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
